Application of "Precision Medicine" Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient.
作者信息
Rosa Rossana, Rudin Susan D, Rojas Laura J, Perez-Cardona Armando, Aragon Laura, Nicolau David P, Perez Federico, Hujer Andrea M, Tekin Akin, Martinez Octavio, Camargo Jose F, Bonomo Robert A, Abbo Lilian M
机构信息
Department of Medicine, Jackson Memorial Hospital.
Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida.
出版信息
Clin Infect Dis. 2017 Aug 15;65(4):701-702. doi: 10.1093/cid/cix387.
Abstract
摘要
相似文献
1
Application of "Precision Medicine" Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient.通过对一名多脏器移植患者广泛耐药肺炎克雷伯菌进行分子特征分析来应用“精准医学”
Clin Infect Dis. 2017 Aug 15;65(4):701-702. doi: 10.1093/cid/cix387.
2
Kidney transplant recipients infected with blaKPC-2-producing Klebsiella pneumoniae.感染产 blaKPC-2 型肺炎克雷伯菌的肾移植受者。
Nefrologia. 2015;35(3):340-3. doi: 10.1016/j.nefro.2015.02.002. Epub 2015 Jun 19.
3
Liver Transplantation and Gut Microbiota Profiling in a Child Colonized by a Multi-Drug Resistant : A New Approach to Move from Antibiotic to "Eubiotic" Control of Microbial Resistance.肝移植和肠道微生物组分析在一个被多药耐药菌定植的儿童中：从抗生素到“生态友好型”控制微生物耐药的新方法。
Int J Mol Sci. 2018 Apr 25;19(5):1280. doi: 10.3390/ijms19051280.
4
First outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Constantine, Algeria.阿尔及利亚君士坦丁首次出现产OXA-48型碳青霉烯耐药肺炎克雷伯菌分离株疫情。
Int J Antimicrob Agents. 2015 Dec;46(6):725-7. doi: 10.1016/j.ijantimicag.2015.08.005. Epub 2015 Sep 9.
5
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.高产碳青霉烯酶耐药肺炎克雷伯菌引起的粘菌素耐药菌血症相关死亡率：不使用粘菌素和碳青霉烯类药物联合治疗的重要性。
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00406-17. Print 2017 Aug.
6
Fosfomycin for multidrug treatment of Klebsiella pneumoniae carbapenemase bacteremia.磷霉素用于肺炎克雷伯菌碳青霉烯酶菌血症的多药联合治疗。
Ann Pharmacother. 2015 Mar;49(3):366-7. doi: 10.1177/1060028014564395.
7
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.肺炎克雷伯菌：在一名肾移植患者的抗菌治疗过程中，产生了碳青霉烯类和替加环素耐药的混合种群。
Clin Microbiol Infect. 2012 Jan;18(1):61-6. doi: 10.1111/j.1469-0691.2011.03482.x. Epub 2011 Jul 1.
8
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.双碳青霉烯类方案治疗泛耐药肺炎克雷伯菌血流感染的协同活性及有效性
J Antimicrob Chemother. 2014 Jun;69(6):1718-20. doi: 10.1093/jac/dku027. Epub 2014 Feb 11.
9
Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen.在一名肝移植受者中，使用基于磷霉素的多药方案成功治疗广泛耐药肺炎克雷伯菌的播散性感染。
Transpl Infect Dis. 2016 Oct;18(5):777-781. doi: 10.1111/tid.12578. Epub 2016 Sep 7.
10
Is combination therapy for carbapenem-resistant Klebsiella pneumoniae the new standard of care?针对耐碳青霉烯类肺炎克雷伯菌的联合治疗是新的治疗标准吗？
Expert Rev Anti Infect Ther. 2015 Apr;13(4):405-7. doi: 10.1586/14787210.2015.1018825. Epub 2015 Feb 24.
引用本文的文献
1
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations.黏菌素在新型β-内酰胺/β-内酰胺酶抑制剂联合应用时代的作用
Antibiotics (Basel). 2022 Feb 20;11(2):277. doi: 10.3390/antibiotics11020277.
2
Simultaneous Infection with and Pseudomonas aeruginosa Harboring Multiple Carbapenemases in a Returning Traveler Colonized with Candida auris.在一名携带耳念珠菌定植的归国旅行者中同时感染 和携带多种碳青霉烯酶的铜绿假单胞菌。
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01466-19.
3
Polymyxins: To Combine or Not to Combine?多粘菌素：联合还是不联合？
Antibiotics (Basel). 2019 Apr 10;8(2):38. doi: 10.3390/antibiotics8020038.
4
Case Report of an Extensively Drug-Resistant Infection With Genomic Characterization of the Strain and Review of Similar Cases in the United States.广泛耐药感染病例报告及菌株基因组特征分析与美国类似病例综述
Open Forum Infect Dis. 2018 Apr 6;5(5):ofy074. doi: 10.1093/ofid/ofy074. eCollection 2018 May.
5
Discordance with Activity: Humanized Exposures of Ceftazidime-Avibactam, Aztreonam, and Tigecycline Alone and in Combination against New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in a Murine Lung Infection Model.与活性的不一致：在小鼠肺部感染模型中，头孢他啶-阿维巴坦、氨曲南和替加环素单独及联合使用对产新德里金属β-内酰胺酶的肺炎克雷伯菌的人源化暴露情况。
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00486-17. Print 2017 Jul.
本文引用的文献
1
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?头孢他啶-阿维巴坦和氨曲南能否克服肠杆菌科细菌中金属β-内酰胺酶介导的β-内酰胺耐药性？
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02243-16. Print 2017 Apr.
2
Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient.肾移植患者中由产金属β-内酰胺酶的嗜麦芽窄食单胞菌引起的血流感染的成功治疗
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5130-4. doi: 10.1128/AAC.00264-16. Print 2016 Sep.
3
Carbapenemase-producing Enterobacteriaceae.产碳青霉烯酶肠杆菌科细菌
Semin Respir Crit Care Med. 2015 Feb;36(1):74-84. doi: 10.1055/s-0035-1544208. Epub 2015 Feb 2.
4
Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria.NDM型碳青霉烯酶在革兰氏阴性菌中的全球传播。
Biomed Res Int. 2014;2014:249856. doi: 10.1155/2014/249856. Epub 2014 Mar 26.
5
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.碳青霉烯类药物及对照药物的人体模拟给药方案对产NDM-1肠杆菌科细菌的体内疗效。
Antimicrob Agents Chemother. 2014;58(3):1671-7. doi: 10.1128/AAC.01946-13. Epub 2013 Dec 30.
6
Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers.人体模拟研究表明，氨曲南和氨曲南-阿维巴坦对包括产金属β-内酰胺酶在内的具有挑战性的革兰氏阴性菌具有活性。
Antimicrob Agents Chemother. 2013 Jul;57(7):3299-306. doi: 10.1128/AAC.01989-12. Epub 2013 May 6.
Zotero 插件